Predictive performance of machine learning compared to statistical methods in time-to-event analysis of cardiovascular disease: a systematic review protocol

被引:2
作者
Suliman, Abubaker [1 ,2 ]
Masud, Mohammad [1 ]
Serhani, Mohamed Adel [3 ]
Abdullahi, Aminu S. [2 ]
Oulhaj, Abderrahim [4 ]
机构
[1] United Arab Emirates Univ, Coll Informat Technol, Al Ain, U Arab Emirates
[2] United Arab Emirates Univ, Inst Publ Hlth, Coll Med & Hlth Sci, Al Ain, U Arab Emirates
[3] Univ Sharjah, Coll Comp & Informat, Sharjah, U Arab Emirates
[4] Khalifa Univ, Coll Med & Hlth Sci, Dept Publ Hlth & Epidemiol, Abu Dhabi, U Arab Emirates
关键词
Cardiovascular Disease; Coronary heart disease; Randomized Controlled Trial; Observational Study; RISK; APPLICABILITY; PROBAST; MODEL; BIAS;
D O I
10.1136/bmjopen-2023-082654
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Globally, cardiovascular disease (CVD) remains the leading cause of death, warranting effective management and prevention measures. Risk prediction tools are indispensable for directing primary and secondary prevention strategies for CVD and are critical for estimating CVD risk. Machine learning (ML) methodologies have experienced significant advancements across numerous practical domains in recent years. Several ML and statistical models predicting CVD time-to-event outcomes have been developed. However, it is not known as to which of the two model types-ML and statistical models-have higher discrimination and calibration in this regard. Hence, this planned work aims to systematically review studies that compare ML with statistical methods in terms of their predictive abilities in the case of time-to-event data with censoring.Methods Original research articles published as prognostic prediction studies, which involved the development and/or validation of a prognostic model, within a peer-reviewed journal, using cohort or experimental design with at least a 12-month follow-up period will be systematically reviewed. The review process will adhere to the Critical Appraisal and Data Extraction for Systematic Reviews of Prediction Modelling Studies checklist.Ethics and dissemination Ethical approval is not required for this review, as it will exclusively use data from published studies. The findings of this study will be published in an open-access journal and disseminated at scientific conferences.PROSPERO registration number CRD42023484178.
引用
收藏
页数:5
相关论文
共 29 条
[1]  
[Anonymous], 2023, Cardiovascular diseases (CVDs) fact sheet
[2]  
[Anonymous], 2013, ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American college of cardiology/American heart Association task force on practice guidelines
[3]  
Collett D., MODELLING SURVIVAL D
[4]   Protocol for development of a reporting guideline (TRIPOD-AI) and risk of bias tool (PROBAST-AI) for diagnostic and prognostic prediction model studies based on artificial intelligence [J].
Collins, Gary S. ;
Dhiman, Paula ;
Andaur Navarro, Constanza L. ;
Ma, Ji ;
Hooft, Lotty ;
Reitsma, Johannes B. ;
Logullo, Patricia ;
Beam, Andrew L. ;
Peng, Lily ;
Van Calster, Ben ;
van Smeden, Maarten ;
Riley, Richard D. ;
Moons, Karel G. M. .
BMJ OPEN, 2021, 11 (07)
[5]  
covidence, Covidence -Better literature review management
[6]   General cardiovascular risk profile for use in primary care - The Framingham Heart Study [J].
D'Agostino, Ralph B. ;
Vasan, Ramachandran S. ;
Pencina, Michael J. ;
Wolf, Philip A. ;
Cobain, Mark ;
Massaro, Joseph M. ;
Kannel, William B. .
CIRCULATION, 2008, 117 (06) :743-753
[7]   A guide to systematic review and meta-analysis of prediction model performance [J].
Debray, Thomas P. A. ;
Damen, Johanna A. A. G. ;
Snell, Kym I. E. ;
Ensor, Joie ;
Hooft, Lotty ;
Reitsma, Johannes B. ;
Riley, Richard D. ;
Moons, Karel G. M. .
BMJ-BRITISH MEDICAL JOURNAL, 2017, 356
[8]  
Desai RJ, 2019, JAMA NETW OPEN, V2, DOI [10.1001/jamanetworkopen.2019.18962, 10.1001/jamanetworkopen.2019.10626]
[9]   A NEURAL-NETWORK MODEL FOR SURVIVAL-DATA [J].
FARAGGI, D ;
SIMON, R .
STATISTICS IN MEDICINE, 1995, 14 (01) :73-82
[10]   Cardiovascular disease risk prediction models: challenges and perspectives [J].
Farzadfar, Farshad .
LANCET GLOBAL HEALTH, 2019, 7 (10) :E1288-E1289